Serko Limited — Director's Dealing 2020

Nov 5, 2020

==> picture [100 x 28] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		Serko Limited
Date this disclosure made:			5-Nov-20
Date of last disclosure:			8-Oct-20
Director or senior manager giving disclosure
Full name(s):		Claudia Batten
Name of listed issuer:		Serko Limited
Name of related body corporate (if applicable):		Not applicable
Position held in listed issuer:		Director
Summary of acquisition or disposal of relevant interest(excluding specified derivatives)
Class of affected quoted financial products:		Ordinary shares
Nature of the affected relevant interest(s):		Beneficial owner of ordinary shares held in
		custody for Claudia Batten pursuant to Non-
		Executive Director Fixed Trading	Plan
For that relevant interest-
Number held in class before acquisition or disposal:		41,266.62
Number held in class after acquisition or disposal:		42,070.92
Current registered holder(s):		Unknown
Registered holder(s) once transfers are registered:		Custodial Services Limited as custodian for
		Claudia Batten
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:			3
Details of transactions requiring disclosure-
Date of transaction:			3-Nov-20
Nature of transaction:		On market purchase of shares pursuant to
		the Non-Executive Director Fixed Trading Plan
Name of any other party or parties to the transaction (if known):		Unknown
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If		1. $3,583.42 ($4.92/share)
the consideration was not in cash and cannot be readily by converted into a cash value, describe the		2. $26.99 ($4.91/share)
consideration:		3. $345.98 ($4.91/share)
		Total: $3,956.39
Number of financial products to which the transaction related:		1. 728.34
		2. 5.50
		3. 70.46
		Total: 804.3
If the issuer has a financial products trading policy that prohibits directors or senior managers from
trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period:		Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the		Not applicable
closed period:
Date of the prior written clearance (if any):		Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:		Ordinary shares
Nature of relevant interest:		Registered holder and beneficial owner
_For that relevant interest,- _
Number held in class:		Registered holder and beneficial owner of
		83,454 ordinary shares
Current registered holder(s):		Claudia Batten
For a derivative relevant interest,-
Type of derivative:		Not applicable
Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying financial products (ifany):		Not applicable
A statement as to whether the derivative is cash settled or physically settled:		Not applicable
Maturity date of the derivative (if any):		Not applicable
Expiry date of the derivative (if any):		Not applicable
The price's specified terms (if any):		Not applicable
Any other details needed to understand how the amount of the consideration payable under thederivative or the value of the derivative is affected by the value of the underlying financial products:		Not applicable
For that derivative relevant interest,-
Parties to the derivative:		Not applicable
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in thederivative:		Not applicable
CertificationI certify that, to the best of my knowledge and belief, the information contained in this disclosure iscorrect and that I am duly authorised to make this disclosure by all persons for whom it is made.Signature of director or officer:Date of signature:
I certify that, to the best of my knowledge and belief, the information contained in this disclosure iscorrect and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:		5-Nov-20